Morgans names the best ASX 200 stocks to buy in June

Morgans expects good returns from these top ASX 200 shares over the next 12 months.

| More on:
Three people in a corporate office pour over a tablet, ready to invest.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Every month, analysts at Morgans pick out their best ASX stock ideas.

These are the ASX stocks that the broker thinks offer the highest risk-adjusted returns over a 12-month timeframe. Morgans notes that they are supported by a higher-than-average level of confidence.

Among its best ideas for June are the two ASX 200 stocks listed below. Here's what the broker is saying about them:

TechnologyOne Ltd (ASX: TNE)

Morgans thinks that this enterprise software provider's shares are a great option for investors this month and has added them to its best ideas list.

The broker likes the ASX 200 stock due to its large cash balance, strong returns, and impressive track record of earnings growth. It said:

TNE is an Enterprise Resource Planning (aka Accounting) company. It's one of the highest quality companies on the ASX with an impressive ROE, nearly $200m of net cash and a 30-year history of growing its earnings by ~15% and its dividend ~10% per annum. As a result of its impeccable track record TNE trades on high PE. With earnings growth looking likely to accelerate towards 20% pa, we think TNE's trading multiple is likely to expand from here.

Morgans has an add rating and $20.50 price target on its shares. This implies potential upside of 12% for investors.

ALS Ltd (ASX: ALQ)

Another new addition to its best ideas list in June is testing services company ALS.

The broker highlights the ASX 200 stock's (sustainable) leadership position as a reason to buy. It also believes that ALS is about to deliver margin improvements, which will be a boost to its earnings. And with copper and gold prices at high levels, it believes demand for its services will be strong. The broker commented:

ALQ is the dominant global leader in geochemistry testing (>50% market share), which is highly cash generative and has little chance of being competed away. Looking forward, ALQ looks poised to benefit from margin recovery in Life Sciences, as well as a cyclical volume recovery in Commodities (exploration). Timing around the latter is less certain, though our analysis suggests this may not be too far away (3-12 months). All the while, gold and copper prices – the key lead indicators for exploration – are gathering pace.

Morgans has an add rating and $15.50 price target on the company's shares. This suggests that they could rise 7% from current levels. It also expects a dividend yield of almost 3% over the next 12 months.

Motley Fool contributor James Mickleboro has positions in Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two businesspeople walk together in an office, smiling as they enjoy a good business relationship.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man sees some good news on his phone and gives a little cheer.
Broker Notes

These ASX shares could rise 20% and ~40%

Analysts think buyers of these shares could generate big returns over the next 12 months.

Read more »

Exhausted young Caucasian woman lying on comfortable sofa in living room sleeping after hard-working day, tired millennial female fall asleep on couch at home, take nap or daydream, fatigue concept
Healthcare Shares

ResMed shares are in a two-month lull. Is this a chance to buy?

ResMed shares are still trading below the price targets of several brokers.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Morgans names more of the best ASX stocks to buy in June

These ASX stocks are highly rated by analysts at Morgans in June.

Read more »

a man raises his fists to the air in joyous celebration while learning some exciting good news via his computer screen in an office setting.
Broker Notes

Guess which ASX 100 stock has 'high quality' earnings and could rise 22%

Goldman Sachs thinks big returns could be on the cards for buyers of this stock.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Buy this ASX 200 stock for an 11% gain and 4%+ dividend yield

Bell Potter is bullish about this stock. But why?

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Financial Shares

Beaten-up ASX 200 stock rebounds 15%. Macquarie says more to come

The sell-off could be unfounded, one broker says.

Read more »